MedDataX Logo

Two Measures of Tactile Acuity in CRPS Type I Patients

NCT ID: NCT01888783

Last Updated: 2013-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate whether two different measures of tactile acuity lead to comparable results in patients diagnosed with CRPS Type I of the upper extremity. Additionally patients with a neuropathy of the median nerve and healthy controls are included.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CRPS Type I of the Upper Extremity Neuropathy of the Median Nerve Healthy Controls

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

CRPS Type I tactile acuity 2-point-discrimination Grating Orientation Task sensory signs

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CRPS Type I

Patients diagnosed with complex regional pain syndrome type I of the upper limb

Group Type EXPERIMENTAL

Tactile acuity measured by 2PD and the GOT

Intervention Type OTHER

For a detailed description of the methods see "outcome measures"

Median Nerve Neuropathy

Patients diagnosed with a neuropathy of the median nerve of the upper limb.

Group Type ACTIVE_COMPARATOR

Tactile acuity measured by 2PD and the GOT

Intervention Type OTHER

For a detailed description of the methods see "outcome measures"

Healthy Controls

Healthy adult persons.

Group Type ACTIVE_COMPARATOR

Tactile acuity measured by 2PD and the GOT

Intervention Type OTHER

For a detailed description of the methods see "outcome measures"

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tactile acuity measured by 2PD and the GOT

For a detailed description of the methods see "outcome measures"

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

2-point-discrimination (2PD) Grating Orientation Task (GOT)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with CRPS Type I according to the "Budapest Criteria"
* Patients diagnosed with a neuropathy of the median nerve
* Healthy Controls,matched in age and gender to both patient cohorts

Exclusion Criteria

* intolerable hyperalgesia
* lesions at the fingertips
* high grade digit contracture
* central neurologic disorders
* psychiatric disorders
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ruhr University of Bochum

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christoph Maier, Prof. Dr.

Prof. Dr. med Christoph Maier, Head Dep. of Pain Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christoph Maier, Prof. Dr.

Role: STUDY_CHAIR

Ruhr University Bochum

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Pain Medicine, BG Universitätsklinikum Bergmannsheil GmbH

Bochum, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christoph Maier, Prof. Dr.

Role: CONTACT

Phone: +49 2343023402

Email: [email protected]

Marianne David, Dr.

Role: CONTACT

Phone: +49 2343023324

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christoph Maier, Prof. Dr.

Role: primary

Marianne David, Dr.

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GOT_CRPS2013

Identifier Type: -

Identifier Source: org_study_id